Clemson University’s ‘bioprinting’ central to new businesses
New businesses are beginning to form around a technology that was created at Clemson University and could one day help doctors engineer
kidneys, livers and other organs for transplant into the human body, according to The Greenville News.
“The emerging field of tissue ‘bioprinting’ was born at Clemson University in 2003, when former bioengineering professor Thomas Boland filed a patent titled ‘Ink-jet printing of viable cells,’ according to Martine LaBerge, chair of the department,” The News reported.
Now Izumi International, a Greenville firm, is exploring bioprinting as a business, according to The News.
Another company, Organovo, “has an exclusive deal with Clemson regarding the technology for ink-jet cell printing,” The News reported.
Researchers in Clemson’s bioengineering department still use bioprinting for a variety of research. Printed models of tumors, for example, are helping test chemotherapy drugs.
Read the full story in The Greenville News here.
To learn more about Organovo, click here.